Literature DB >> 8210162

Indefinite survival of human skin allografts in patients with long-term immunosuppression.

J R Wendt1, T R Ulich, E P Ruzics, J R Hostetler.   

Abstract

The transplantation of a sufficient quantity of good quality skin is of great clinical importance. Severe burn patients lack adequate skin donor sites to cover their wounds with autografts. Patients with severe injuries and burns of areas such as the entire face are presently reconstructed with multiple full- or split-thickness skin grafts. The final result is a patchwork appearance of skin with inferior qualities to normal full-thickness facial skin. Before structures such as hands should be transplanted, each individual tissue component should be evaluated to determine whether the tissue will survive and function with immunosuppression. Skin is obviously an important part of the hand. One hypothesis tested is the ability of transplanted human skin to survive indefinitely with long-term immunosuppression. The early detection of rejection of transplanted organs is paramount in reversing the rejection phenomena and hence saving the transplanted organ. Another hypothesis tested is the ability of a synchronously placed, same-donor, same-recipient skin graft to be used to detect rejection of a transplanted organ. As the skin and kidney from the same donor have similar antigens and the transplantation of both these tissues is to the same recipient and immunological system, it is hypothesized that there will be a correlation of rejection between the transplanted skin and the transplanted organ. To test the above hypotheses a small skin graft was placed on renal transplant patients synchronously with renal transplantation. The skin allografts were followed by direct observation and biopsy at regular intervals and at the time of suspected rejection. The patients were treated with the usual renal transplant immunosuppressant drugs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8210162     DOI: 10.1097/00000637-199404000-00016

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  2 in total

1.  Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival.

Authors:  Mayuko Uehara; Xiaofei Li; Amir Sheikhi; Nooshin Zandi; Brian Walker; Bahram Saleh; Naima Banouni; Liwei Jiang; Farideh Ordikhani; Li Dai; Merve Yonar; Ishaan Vohra; Vivek Kasinath; Dennis P Orgill; Ali Khademhosseini; Nasim Annabi; Reza Abdi
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

2.  The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation.

Authors:  Cheng-Hung Lin; Madonna R Anggelia; Hui-Yun Cheng; Aline Yen Ling Wang; Wen-Yu Chuang; Chih-Hung Lin; W P Andrew Lee; Fu-Chan Wei; Gerald Brandacher
Journal:  Cell Mol Immunol       Date:  2019-11-21       Impact factor: 11.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.